Correction: All-purpose nanostrategy based on dose deposition enhancement, cell cycle arrest, DNA damage, and ROS production as prostate cancer radiosensitizer for potential clinical translation.
Nanoscale
; 14(17): 6670, 2022 May 05.
Article
en En
| MEDLINE
| ID: mdl-35466988
Texto completo:
1
Banco de datos:
MEDLINE
Idioma:
En
Año:
2022
Tipo del documento:
Article